Patient-reported outcomes of patients with advanced renal cell carcinoma (aRCC) treated with first-line nivolumab plus cabozantinib versus sunitinib: The CheckMate 9ER trial Meeting Abstract
| Authors: | Cella, D.; Choueiri, T. K.; Blum, S. I.; Ejzykowicz, F.; Hamilton, M.; Zhang, J.; Ivanescu, C.; Motzer, R. J. |
| Abstract Title: | Patient-reported outcomes of patients with advanced renal cell carcinoma (aRCC) treated with first-line nivolumab plus cabozantinib versus sunitinib: The CheckMate 9ER trial |
| Meeting Title: | 2021 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2021 Feb 11-13 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-02-20 |
| Language: | English |
| ACCESSION: | WOS:000636801500300 |
| DOI: | 10.1200/JCO.2021.39.6_suppl.285 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 285 -- Source: Wos |
